Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy

S. Pirelli, A. Moreo, G. Piccalo, A. Corato, R. Sara, G. B. Danzi, E. Corrada, D. Massa, C. De Vita

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The aim of this study was to assess the safety and prognostic value of dipyridamole-201Tl imaging very early after acute myocardial infarction in patients treated with thrombolytic therapy. Fifty-two consecutive patients with an uncomplicated clinical course underwent quantitative planar dipyridamole-201Tl imaging 2-5 days after acute myocardial infarction. The patients were followed for 14 ± 7 months after discharge. No major complications occurred during the test. Of the 30 patients with redistribution, five (16.6%) developed in-hospital unstable angina as against none of the 22 patients without redistribution. During follow-up, a total of five late cardiac events were observed: two deaths and two cases of unstable angina in the group with reversible defects and one reinfarction in the group with fixed defects. The 1-year actuarial probability of being free of cardiac events was, respectively, 66 ± 10% and 94 ± 5% in the patients with and without redistribution (P <0.01). In conclusion, in patients treated with thrombolysis, dipyridamole-201Tl imaging very early after uncomplicated acute myocardial infarction is a feasible and safe test. Patients with fixed defects appear to be at low risk and may be candidates for early discharge; the presence of redistribution identifies a subgroup of patients who may benefit from further careful clinical evaluation.

Original languageEnglish
Pages (from-to)925-930
Number of pages6
JournalEuropean Heart Journal
Volume18
Issue number6
Publication statusPublished - 1997

Fingerprint

Dipyridamole
Thallium
Thrombolytic Therapy
Myocardial Infarction
Unstable Angina
Safety

Keywords

  • Tl scintigraphy
  • Acute myocardial infarction
  • Dipyridamole
  • Thrombolysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pirelli, S., Moreo, A., Piccalo, G., Corato, A., Sara, R., Danzi, G. B., ... De Vita, C. (1997). Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy. European Heart Journal, 18(6), 925-930.

Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy. / Pirelli, S.; Moreo, A.; Piccalo, G.; Corato, A.; Sara, R.; Danzi, G. B.; Corrada, E.; Massa, D.; De Vita, C.

In: European Heart Journal, Vol. 18, No. 6, 1997, p. 925-930.

Research output: Contribution to journalArticle

Pirelli, S, Moreo, A, Piccalo, G, Corato, A, Sara, R, Danzi, GB, Corrada, E, Massa, D & De Vita, C 1997, 'Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy', European Heart Journal, vol. 18, no. 6, pp. 925-930.
Pirelli, S. ; Moreo, A. ; Piccalo, G. ; Corato, A. ; Sara, R. ; Danzi, G. B. ; Corrada, E. ; Massa, D. ; De Vita, C. / Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy. In: European Heart Journal. 1997 ; Vol. 18, No. 6. pp. 925-930.
@article{356d9710faec4858a86b3435bdd31a78,
title = "Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy",
abstract = "The aim of this study was to assess the safety and prognostic value of dipyridamole-201Tl imaging very early after acute myocardial infarction in patients treated with thrombolytic therapy. Fifty-two consecutive patients with an uncomplicated clinical course underwent quantitative planar dipyridamole-201Tl imaging 2-5 days after acute myocardial infarction. The patients were followed for 14 ± 7 months after discharge. No major complications occurred during the test. Of the 30 patients with redistribution, five (16.6{\%}) developed in-hospital unstable angina as against none of the 22 patients without redistribution. During follow-up, a total of five late cardiac events were observed: two deaths and two cases of unstable angina in the group with reversible defects and one reinfarction in the group with fixed defects. The 1-year actuarial probability of being free of cardiac events was, respectively, 66 ± 10{\%} and 94 ± 5{\%} in the patients with and without redistribution (P <0.01). In conclusion, in patients treated with thrombolysis, dipyridamole-201Tl imaging very early after uncomplicated acute myocardial infarction is a feasible and safe test. Patients with fixed defects appear to be at low risk and may be candidates for early discharge; the presence of redistribution identifies a subgroup of patients who may benefit from further careful clinical evaluation.",
keywords = "Tl scintigraphy, Acute myocardial infarction, Dipyridamole, Thrombolysis",
author = "S. Pirelli and A. Moreo and G. Piccalo and A. Corato and R. Sara and Danzi, {G. B.} and E. Corrada and D. Massa and {De Vita}, C.",
year = "1997",
language = "English",
volume = "18",
pages = "925--930",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy

AU - Pirelli, S.

AU - Moreo, A.

AU - Piccalo, G.

AU - Corato, A.

AU - Sara, R.

AU - Danzi, G. B.

AU - Corrada, E.

AU - Massa, D.

AU - De Vita, C.

PY - 1997

Y1 - 1997

N2 - The aim of this study was to assess the safety and prognostic value of dipyridamole-201Tl imaging very early after acute myocardial infarction in patients treated with thrombolytic therapy. Fifty-two consecutive patients with an uncomplicated clinical course underwent quantitative planar dipyridamole-201Tl imaging 2-5 days after acute myocardial infarction. The patients were followed for 14 ± 7 months after discharge. No major complications occurred during the test. Of the 30 patients with redistribution, five (16.6%) developed in-hospital unstable angina as against none of the 22 patients without redistribution. During follow-up, a total of five late cardiac events were observed: two deaths and two cases of unstable angina in the group with reversible defects and one reinfarction in the group with fixed defects. The 1-year actuarial probability of being free of cardiac events was, respectively, 66 ± 10% and 94 ± 5% in the patients with and without redistribution (P <0.01). In conclusion, in patients treated with thrombolysis, dipyridamole-201Tl imaging very early after uncomplicated acute myocardial infarction is a feasible and safe test. Patients with fixed defects appear to be at low risk and may be candidates for early discharge; the presence of redistribution identifies a subgroup of patients who may benefit from further careful clinical evaluation.

AB - The aim of this study was to assess the safety and prognostic value of dipyridamole-201Tl imaging very early after acute myocardial infarction in patients treated with thrombolytic therapy. Fifty-two consecutive patients with an uncomplicated clinical course underwent quantitative planar dipyridamole-201Tl imaging 2-5 days after acute myocardial infarction. The patients were followed for 14 ± 7 months after discharge. No major complications occurred during the test. Of the 30 patients with redistribution, five (16.6%) developed in-hospital unstable angina as against none of the 22 patients without redistribution. During follow-up, a total of five late cardiac events were observed: two deaths and two cases of unstable angina in the group with reversible defects and one reinfarction in the group with fixed defects. The 1-year actuarial probability of being free of cardiac events was, respectively, 66 ± 10% and 94 ± 5% in the patients with and without redistribution (P <0.01). In conclusion, in patients treated with thrombolysis, dipyridamole-201Tl imaging very early after uncomplicated acute myocardial infarction is a feasible and safe test. Patients with fixed defects appear to be at low risk and may be candidates for early discharge; the presence of redistribution identifies a subgroup of patients who may benefit from further careful clinical evaluation.

KW - Tl scintigraphy

KW - Acute myocardial infarction

KW - Dipyridamole

KW - Thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=0030907537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030907537&partnerID=8YFLogxK

M3 - Article

C2 - 9183583

AN - SCOPUS:0030907537

VL - 18

SP - 925

EP - 930

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 6

ER -